Article · 20 May 2025
Review articlePublished 27 Jul 2016
Treatment of Behcets disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Behçet’s disease is a chronic, relapsing, systemic vasculitis of unknown etiology with the clinical features of mucocutaneous lesions and ocular, vascular, articular, gastrointestinal, urogenital, pulmonary and neurologic involvement. The disease is particularly prevalent in ‘Silk Route’ populations but has a global distribution. Behçet’s disease effects primarily young subjects. The diagnosis is based on clinical criteria, as there is no pathognomonic test. Besides considerable morbidity, the disease confers an increased mortality, mainly due to large vessel (especially pulmonary arterial) and neurologic involvement as well as bowel perforation. No standard therapy has yet been established for the treatment of Behçet’s disease, and a wide spectrum of therapeutic agents have been used with varying success. Treatment of the disease has become much more effective in recent years with the introduction of newer drugs. This paper will aim to provide an overview of the therapeutic approaches including local and systemic agents for the treatment of Behçet’s disease.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Practice.
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 28 Mar 2025
Using
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Erkan Alpsoy”
- BylineArticles whose byline prints “Ayse Akman”